September 21, 2016 / 12:22 PM / a year ago

BRIEF-Redhill Biopharma Ltd and IntelGenx announce RIZAPORT commercialization with pharmatronic co.

1 Min Read

Sept 21 (Reuters) - Redhill Biopharma Ltd :

* Redhill Biopharma and IntelGenx announce RIZAPORT commercialization term sheet with Pharmatronic Co. for Korea

* Pursuant to signing of definitive agreement, Co will grant Pharmatronic exclusive rights to commercialize RIZAPORT in South Korea

* Under term sheet, Co and IntelGenx are to receive an upfront payment and will be eligible to receive additional milestone payments

* Financial terms of term sheet were not disclosed Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below